Statements (74)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
Acquired by a private equity firm
|
| gptkbp:businessModel |
licensing agreements
revenue increase biopharmaceutical development |
| gptkbp:CEO |
Stephen_From
|
| gptkbp:clinicalTrials |
compliance with regulations
patient recruitment Phase 2 multiple phases Phase 3 trials protocol development clinical efficacy published in journals sponsored research safety and efficacy studies various clinical sites oversight processes |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:communityEngagement |
patient advocacy groups
|
| gptkbp:communityPartnerships |
collaborative projects
collaborative ventures |
| gptkbp:corporateSocialResponsibility |
community initiatives
|
| gptkbp:financialPerformance |
annual reports
IP portfolio |
| gptkbp:financials |
quarterly earnings
investor backing |
| gptkbp:focus |
ocular drug delivery
|
| gptkbp:founded |
2008
|
| gptkbp:funding |
venture capital
|
| gptkbp:hasPrograms |
experts in ophthalmology
|
| gptkbp:hasResearchInterest |
industry analysis
|
| gptkbp:headquarters |
gptkb:Waltham,_Massachusetts
|
| gptkbp:historicalResearch |
ongoing studies
|
| https://www.w3.org/2000/01/rdf-schema#label |
EyeGate Pharmaceuticals
|
| gptkbp:investmentFocus |
institutional investors
public disclosures private equity funding |
| gptkbp:market |
competitive landscape
dry eye syndrome new drug applications new therapies emerging therapies leading innovator in ocular therapies new geographic regions |
| gptkbp:marketingStrategy |
focus on innovation
|
| gptkbp:marketSegment |
expansion in ophthalmic market
|
| gptkbp:partnerships |
gptkb:U.S._Department_of_Defense
strategic alliances |
| gptkbp:patentCitation |
multiple patents granted
|
| gptkbp:productLine |
multiple candidates
|
| gptkbp:products |
adverse event reporting
new drug formulations unique delivery systems EG-1962 EyeGate_II_Delivery_System |
| gptkbp:regulatoryCompliance |
FDA_regulations
FDA_approval |
| gptkbp:research |
government grants
|
| gptkbp:research_areas |
eye diseases
|
| gptkbp:researchAndDevelopment |
pipeline expansion
|
| gptkbp:researchFocus |
treatment of retinal diseases
|
| gptkbp:researchInterest |
new technologies
pharmaceutical companies research findings academic partnerships |
| gptkbp:strategicGoals |
long-term vision
|
| gptkbp:supplyChain |
manufacturing partnerships
|
| gptkbp:targetMarket |
ophthalmology
|
| gptkbp:technology |
collaborative research
iontophoresis |
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:type |
public company
|
| gptkbp:website |
www.eyegatepharma.com
|